(BCIM) abrdn s - abrdn Bloomberg - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US0032616098
BCIM: Industrial Metals, Futures Contracts, Collateral
The abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF (BCIM) is designed to track the performance of the Bloomberg Industrial Metals SubindexSM, providing investors with exposure to a basket of industrial metals commodity futures contracts. This ETF is a commodity-focused investment vehicle that aims to remain fully invested in financial instruments that replicate the indexs returns, regardless of market conditions.
By investing in BCIM, investors can gain exposure to the industrial metals sector, which includes metals such as copper, aluminum, and zinc. The ETFs underlying index is composed of futures contracts on these metals, allowing investors to benefit from price movements in the industrial metals market. The funds non-diversified nature means that it may be more susceptible to market volatility, but it also allows for a more focused investment approach.
Analyzing the ETFs technical data, we can see that the price is currently hovering around the 20-day SMA, indicating a relatively stable trend. However, the 50-day and 200-day SMAs suggest a potential downward trend in the medium to long term. Considering the ATR, the price movement is relatively contained, with a 1.16% average true range. Using technical analysis, we can forecast that the price may continue to consolidate around the current levels, potentially breaking out or down in the near future.
From a fundamental perspective, the ETFs AUM of $23.10M USD is relatively small, which may impact liquidity. However, the funds focus on industrial metals provides a unique investment opportunity, as the demand for these metals is closely tied to global economic growth and infrastructure development. Combining fundamental and technical analysis, we can forecast that the price of BCIM may be influenced by the overall trend in industrial metals prices, as well as market sentiment and liquidity conditions. If the global economy continues to grow, driving demand for industrial metals, BCIM may see a price increase, potentially breaking above the 52-week high of $23.22.
Additional Sources for BCIM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BCIM ETF Overview
Market Cap in USD | 23m |
Category | Commodities Focused |
TER | 0.41% |
IPO / Inception | 2021-09-22 |
BCIM ETF Ratings
Growth Rating | -4.67 |
Fundamental | - |
Dividend Rating | 86.3 |
Rel. Strength | -4.02 |
Analysts | - |
Fair Price Momentum | 21.67 USD |
Fair Price DCF | - |
BCIM Dividends
Dividend Yield 12m | 11.09% |
Yield on Cost 5y | 10.78% |
Annual Growth 5y | 54.42% |
Payout Consistency | 88.3% |
Payout Ratio | % |
BCIM Growth Ratios
Growth Correlation 3m | -19.7% |
Growth Correlation 12m | 14.9% |
Growth Correlation 5y | -24.9% |
CAGR 5y | -0.80% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | -0.63 |
Alpha | -11.14 |
Beta | 0.626 |
Volatility | 16.86% |
Current Volume | 2.6k |
Average Volume 20d | 2.2k |
As of June 16, 2025, the stock is trading at USD 20.68 with a total of 2,563 shares traded.
Over the past week, the price has changed by -1.36%, over one month by -0.53%, over three months by -6.53% and over the past year by -1.06%.
Neither. Based on ValueRay´s Analyses, abrdn s - abrdn Bloomberg is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -4.67 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCIM is around 21.67 USD . This means that BCIM is currently overvalued and has a potential downside of 4.79%.
abrdn s - abrdn Bloomberg has no consensus analysts rating.
According to our own proprietary Forecast Model, BCIM abrdn s - abrdn Bloomberg will be worth about 24.2 in June 2026. The stock is currently trading at 20.68. This means that the stock has a potential upside of +17.02%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.2 | 17% |